Navigation Links
TIBCO Spotfire Puts the Spotlight on Screening at InfoTech for Pharma and Biotech
Date:5/20/2008

Christian Marcazzo's Presentation at May Conference to Show How Pharma

Research Benefits from Advances in Analytics

SOMERVILLE, Mass., May 20 /PRNewswire-FirstCall/ -- Spotfire, a division of TIBCO Software Inc. (Nasdaq: TIBX), today announced that Christian Marcazzo, Senior Director Life Sciences Analytics, will present 'Applying Next Generation Business Intelligence to Pharma R&D' at the InfoTech for Pharma and Biotech Conference being held May 20 & 21 in Basel, Switzerland. Mr. Marcazzo's presentation will offer participants insight into how they can leverage critical data to speed insights and prompt better business decisions at pharmaceutical organizations.

For the past ten years, Spotfire's software has been used to enable decision making at all of the top 25 pharmaceutical companies. In his presentation, Marcazzo will explain how the newest generation of the Spotfire platform offers research groups new and powerful workflows that can accelerate the entire screening operation including high-throughput screening, secondary screening, and high-content screening.

"This is the first release of the Spotfire platform which we are recommending for applications in Screening," said Marcazzo. "With the curve-fitting and curve-drawing capabilities, we've developed what I believe will be game changing for analysis of plate based screening data; in particular when looking at dose response screens."

The TIBCO Spotfire(R) enterprise analytics platform allows users to leverage standard interfaces and Business Intelligence (BI) data to create user experiences that speed insights and prompt better business decisions. This type of speed and flexibility is difficult to achieve quickly with traditional BI solutions. The latest release also provides an enhanced set of application programming interfaces (APIs) to allow partners and customers to build analytics applications for any business process. These APIs make it easier for companies to create a seamlessly integrated user experience, by customizing the user interface and even developing new data visualizations for the TIBCO Spotfire(R) Web Player. Security improvements provide better integration to existing infrastructure for internal and external use over the web.

The conference will be at the Radisson SAS Hotel Basel. Mr. Marcazzo will present on Wednesday, May 21st at 12:30 (local time).

About the Speaker:

Christian Marcazzo is responsible for TIBCO Spotfire's strategy, marketing, and business development for the pharmaceutical industry. He has spent the last 10 years bringing new technologies to market to support the drug discovery and development process at companies including InforSense Ltd in London, LION bioscience in Heidelberg, Germany and Molecular Applications Group in Palo Alto, CA. Christian has a BA in Molecular and Cell Biology from the University of California, Berkeley.

About Spotfire

Spotfire, a division of TIBCO Software Inc., is a leading provider of enterprise analytics software for next generation business intelligence. Spotfire offers a visual and interactive experience that helps professionals quickly discover new and actionable insights in information. Distinguished by its speed to insight and adaptability to specific business challenges, Spotfire rapidly reveals unseen threats and new opportunities, creating significant economic value. Spotfire customers include industry leaders among the Global 2000 that have deployed Spotfire analytics to gain an information advantage over their competitors. For more information, visit http://spotfire.tibco.com

TIBCO, TIBCO Software, TIBCO Spotfire, TIBCO Spotfire Web Player, and Spotfire are trademarks or registered trademarks of TIBCO Software Inc. and/or its subsidiaries in the United States and/or other countries. All other product and company names and marks mentioned in this document are the property of their respective owners and are mentioned for identification purposes only.

Contacts:

Jim Baptiste Amy Groden-Morrison

Davies Murphy Group, Inc. TIBCO Spotfire Division

(781) 418-2438 (617) 702-1710

spotfire@daviesmurphy.com amorriso@tibco.com

http://www.daviesmurphy.com http://www.spotfire.com


'/>"/>
SOURCE Spotfire
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. TIBCO Spotfire and Integromics Partner on Development of Genomics Platform for Province of Andalusia
2. Increased Drug Related Cardiac Toxicity Leads Gwathmey Preclinical Testing Services to Create Novel Cardionomics(TM) Services for Preclinical Cardiac Safety Screening of Drug Candidates
3. Enterix Inc. Launches Its Point-of-Care Test for Colorectal Cancer Screening
4. Olympus FluoroPoint(TM) System Provides High-Sensitivity Single Molecule and Protein Interaction Analysis for Screening and Research
5. Liberty Screening Services Hires Top Executive to Meet Explosive Demand for its Background-Screening Services
6. Quest Diagnostics Campaign Challenges Colorectal Cancer Screening Status Quo
7. Spermatech Selects Evotec as Partner for High-Throughput Screening and Lead Discovery
8. Colon Cancer Screening Laws Now Cover Half of U.S. Population
9. Data show a decline in cystic fibrosis since introduction of prenatal carrier screening
10. National Fire Protection Association (NFPA) Sets New National Standard for CO Screening by Pulse CO-Oximetry(TM)
11. National Association of Emergency Medical Technicians (NAEMT) Supports Prehospital Screening for Carbon Monoxide in the Blood
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... CA (PRWEB) , ... February 24, 2017 , ... Delpor, ... a $224K grant from the National Institute of Mental Health (NIMH) for the further ... on Delpor’s PROZOR technology and is expected to deliver therapeutic levels of ...
(Date:2/24/2017)... -- Symic Bio, a biopharmaceutical company focused on matrix ... announced today the completion of enrollment for the SHIELD ... trial will evaluate the safety and efficacy of SB-030, ... restenosis following angioplasty. "We,re pleased to ... Nathan Bachtell , M.D., Chief Medical Officer of ...
(Date:2/24/2017)... 2017 China Biologic Products, Inc. (NASDAQ: CBPO) ("China ... company in China, today announced its financial results for the ... Fourth Quarter 2016 Financial Highlights Total ... in RMB terms, or increased by 13.6% in USD terms ... of 2015. Gross profit increased by 13.3% ...
(Date:2/23/2017)... 2017 ... share data, unaudited)Three Months Ended December 31,Twelve Months Ended ... $           ... 89026%Aldurazyme Net Product Revenue 3539(10)%9498(4)%Kuvan ... Product Revenue  756025%297303(2)%Vimizim Net Product ...
Breaking Biology Technology:
(Date:2/24/2017)... BARCELONA, Spain , Feb. 24, 2017  EyeLock LLC, ... will demonstrate its elite iris biometric solution on ... with X16 LTE at Mobile World Congress ... in Qualcomm,s Booth in Hall 3, Stand ... contains the Qualcomm Haven™ security platform—a combination ...
(Date:2/16/2017)...  Genos, a community for personal genetic discovery ... Laboratory Accreditation from the College of American Pathologists ... that meet stringent requirements around quality, accuracy and ... "Genos is committed to maintaining the highest ... to be receiving CAP accreditation," said Jill ...
(Date:2/10/2017)... Research and Markets has announced the addition of ... Commercial Aspects" to their offering. ... Biomarkers play an important ... selection of treatment as well for monitoring the results. There ... modern medicine. Biochip/microarray technologies and next generation sequencing are also ...
Breaking Biology News(10 mins):